InvestorsHub Logo
Followers 87
Posts 6669
Boards Moderated 1
Alias Born 09/18/2009

Re: dloggold post# 42577

Thursday, 06/06/2024 9:30:31 PM

Thursday, June 06, 2024 9:30:31 PM

Post# of 42837
Yes, in part, and as I have previously made clear, some of my conclusions, particularly in regards to Novavax, have no basis in fact, and simply reflect a blaringly obvious solution to the unmet needs of both Humanigen and Novavax, as only they can meet for each other with such a high degree of success. I am highly confident in what Dubovsky can contribute toward our international approval and usage of lenz.

My pinned post, which reflects the last communication from Humanigen, focuses on our opportunities as otherwise noted in my post. And I think Sanofi will enable our ability to penetrate the market beyond covid and into oncology and hematology.

I have read and studied the material on Humanigen over the years, just as I read and studied my college textbooks. No relevant communication with management, other than that, except for conveying my appreciation of management, as I am doing now, because I think they are entirely worthy of shareholder support. Hopefully, we'll all have the financial reward they have worked to provide for us, and many more shareholders will share my appreciation of them after that gain is realized.